Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$9.34M |
| 2 |
US Bancorp
USB
|
+$5.68M |
| 3 |
International Flavors & Fragrances
IFF
|
+$3.82M |
| 4 |
Biogen
BIIB
|
+$1.31M |
| 5 |
AT&T
T
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$8.94M |
| 2 |
Compass Minerals
CMP
|
+$8.23M |
| 3 |
Lam Research
LRCX
|
+$2.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.69M |
| 5 |
Amazon
AMZN
|
+$2.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.7% |
| 2 | Healthcare | 17.67% |
| 3 | Communication Services | 16% |
| 4 | Financials | 12.57% |
| 5 | Consumer Staples | 11.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.59T
| $10.4M | 4.02% |
33,052
-1,920
| -5% | -$634K |
|
|
2
Biogen
BIIB
$32B
| $8.82M | 3.39% |
34,306
+4,895
| +17% | +$1.31M |
|
3
Wells Fargo
WFC
$254B
| $8.63M | 3.32% |
211,236
-7,677
| -4% | -$331K |
|
|
4
International Flavors & Fragrances
IFF
$21.5B
| $8.54M | 3.29% |
125,277
+52,277
| +72% | +$3.82M |
|
5
GSK
GSK
$105B
| $8.44M | 3.25% |
232,864
-1,817
| -0.8% | -$64.5K |
|
6
Intel
INTC
$476B
| $8.37M | 3.22% |
235,505
-4,421
| -2% | -$154K |
|
7
TSMC
TSM
$2.17T
| $8.34M | 3.21% |
96,022
-3,136
| -3% | -$297K |
|
8
DuPont de Nemours
DD
$18.7B
| $8.3M | 3.2% |
88,670
-3,304
| -4% | -$310K |
|
|
9
Baxter International
BAX
$13.6B
| $8.27M | 3.19% |
+219,248
| New | +$9.34M |
|
10
AB InBev
BUD
$155B
| $8.26M | 3.18% |
149,299
-1,377
| -0.9% | -$78K |
|
11
Boeing
BA
$169B
| $8.17M | 3.15% |
42,643
+3,447
| +9% | +$754K |
|
12
Kraft Heinz
KHC
$30.3B
| $7.89M | 3.04% |
234,538
+12,404
| +6% | +$429K |
|
13
CVS Health
CVS
$119B
| $7.84M | 3.02% |
112,308
+16,613
| +17% | +$1.18M |
|
14
Adobe
ADBE
$109B
| $7.75M | 2.98% |
15,203
-582
| -4% | -$305K |
|
15
Warner Bros
WBD
$71.6B
| $7.69M | 2.96% |
708,043
+14,655
| +2% | +$183K |
|
|
16
AT&T
T
$173B
| $7.67M | 2.95% |
510,611
+85,764
| +20% | +$1.26M |
|
17
Simon Property Group
SPG
$70.6B
| $7.66M | 2.95% |
70,903
-2,793
| -4% | -$327K |
|
|
18
Amazon
AMZN
$2.79T
| $7.6M | 2.92% |
59,757
-18,485
| -24% | -$2.48M |
|
19
ASML
ASML
$677B
| $7.35M | 2.83% |
12,480
-438
| -3% | -$291K |
|
20
Alphabet (Google) Class A
GOOGL
$4.22T
| $7.33M | 2.82% |
56,000
-2,268
| -4% | -$293K |
|
21
Western Union
WU
$2.28B
| $7.28M | 2.8% |
552,494
-19,790
| -3% | -$243K |
|
|
K
22
DELISTED
Kellanova
K
| $6.88M | 2.65% |
123,070
-4,025
| -3% | -$239K |
|
23
Emerson Electric
EMR
$87.7B
| $6.66M | 2.56% |
68,983
-2,957
| -4% | -$282K |
|
24
Becton Dickinson
BDX
$52.3B
| $6.48M | 2.49% |
25,055
-1,083
| -4% | -$293K |
|
25
Walt Disney
DIS
$186B
| $6.17M | 2.38% |
76,166
+10,880
| +17% | +$929K |
|
Similar funds
Mark Hillman's Q3 2023 Portfolio in Review
As of Q3 2023, Mark Hillman held 57 positions worth $260M, down 8.3% from $283M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Mark Hillman's Q3 2023 filing shows 2 new, 13 increased, 34 reduced and 4 closed positions. Its largest new stake was Baxter International: 219,248 shares worth $8.27M. The largest sale was Enterprise Products Partners, an estimated $8.94M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Communication Services.
- Mark Hillman's largest Q3 2023 buy was Baxter International: 219,248 shares worth $8.27M.
- Mark Hillman added most to International Flavors & Fragrances in Q3 2023, an estimated $3.82M increase.
- Mark Hillman's biggest Q3 2023 reduction was Lam Research, cutting an estimated $2.9M.
- Mark Hillman fully exited Enterprise Products Partners in Q3 2023, selling an estimated $8.94M.
- Mark Hillman's ten largest holdings make up 33% of its $260M portfolio in Q3 2023.
- Mark Hillman opened 2 new positions and closed 4 in Q3 2023.
- Mark Hillman's portfolio value fell 8.3% quarter-over-quarter to $260M.
Based on Hillman Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.